164 related articles for article (PubMed ID: 38275834)
21. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
[TBL] [Abstract][Full Text] [Related]
22. Brain Atrophy Associated with Primary Diffuse Meningeal Melanomatosis.
Ma Y; Xing X; Li Y; Ao R; He M; Lan X; Zhao Y; Zhang J; Yu S
World Neurosurg; 2020 Apr; 136():311-314. PubMed ID: 32004738
[TBL] [Abstract][Full Text] [Related]
23. F-18 fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal melanomatosis.
Lee HJ; Ahn BC; Hwang SW; Cho SK; Kim HW; Lee SW; Hwang JH; Lee J
Korean J Radiol; 2013; 14(2):343-9. PubMed ID: 23483049
[TBL] [Abstract][Full Text] [Related]
24. Ipsilateral metastatic choroidal melanoma responds to systemic immunotherapy.
Morkos M; Jain P; Pavlick AC; Finger PT
Eur J Ophthalmol; 2020 Sep; 30(5):NP69-NP73. PubMed ID: 30943789
[TBL] [Abstract][Full Text] [Related]
25. [Primary diffuse meningeal melanomatosis: a literature review and a case report].
Sitovskaya DA; Verbitsky OP; Petrova YA; Sokolova TV; Zabrodskaya YM
Arkh Patol; 2022; 84(1):27-32. PubMed ID: 35166475
[TBL] [Abstract][Full Text] [Related]
26. Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced
Atkins MB; Lee SJ; Chmielowski B; Tarhini AA; Cohen GI; Truong TG; Moon HH; Davar D; O'Rourke M; Stephenson JJ; Curti BD; Urba WJ; Brell JM; Funchain P; Kendra KL; Ikeguchi AP; Jaslowski A; Bane CL; Taylor MA; Bajaj M; Conry RM; Ellis RJ; Logan TF; Laudi N; Sosman JA; Crockett DG; Pecora AL; Okazaki IJ; Reganti S; Chandra S; Guild S; Chen HX; Streicher HZ; Wolchok JD; Ribas A; Kirkwood JM
J Clin Oncol; 2023 Jan; 41(2):186-197. PubMed ID: 36166727
[TBL] [Abstract][Full Text] [Related]
27. A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma.
Minor DR; Kim KB; Tong RT; Wu MC; Kashani-Sabet M; Orloff M; Eschelman DJ; Gonsalves CF; Adamo RD; Anne PR; Luke JJ; Char D; Sato T
Cancer Biother Radiopharm; 2022 Feb; 37(1):11-16. PubMed ID: 35021863
[No Abstract] [Full Text] [Related]
28. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Hodi FS; Chiarion-Sileni V; Gonzalez R; Grob JJ; Rutkowski P; Cowey CL; Lao CD; Schadendorf D; Wagstaff J; Dummer R; Ferrucci PF; Smylie M; Hill A; Hogg D; Marquez-Rodas I; Jiang J; Rizzo J; Larkin J; Wolchok JD
Lancet Oncol; 2018 Nov; 19(11):1480-1492. PubMed ID: 30361170
[TBL] [Abstract][Full Text] [Related]
29. Nivolumab efficacy in leptomeningeal metastasis of renal cell carcinoma: a case report.
Bonomi L; Bettini AC; Arnoldi E; Chirco A; Ghilardi L; Manara O; Roscigno M; Da Pozzo LF; Tondini CA
Tumori; 2020 Dec; 106(6):NP76-NP78. PubMed ID: 32041500
[TBL] [Abstract][Full Text] [Related]
30. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Long GV; Atkinson V; Lo S; Sandhu S; Guminski AD; Brown MP; Wilmott JS; Edwards J; Gonzalez M; Scolyer RA; Menzies AM; McArthur GA
Lancet Oncol; 2018 May; 19(5):672-681. PubMed ID: 29602646
[TBL] [Abstract][Full Text] [Related]
31. Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature.
Piña Y; Evernden BR; Khushalani N; Margolin K; Tawbi H; Tran ND; Macaulay R; Forsyth P; Peguero E
SAGE Open Med Case Rep; 2021; 9():2050313X211042215. PubMed ID: 34457306
[TBL] [Abstract][Full Text] [Related]
32. [A case of meningeal melanomatosis diagnosed by immunostaining of cerebrospinal fluid].
Tamura Y; Umeda Y; Umeda M; Oyake M; Usuda H; Fujita N
Rinsho Shinkeigaku; 2020 Aug; 60(8):565-568. PubMed ID: 32641630
[TBL] [Abstract][Full Text] [Related]
33. Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.
McDonald MA; Sanghvi P; Bykowski J; Daniels GA
BMC Cancer; 2018 May; 18(1):549. PubMed ID: 29743050
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.
Kreft S; Gesierich A; Eigentler T; Franklin C; Valpione S; Ugurel S; Utikal J; Haferkamp S; Blank C; Larkin J; Garbe C; Schadendorf D; Lorigan P; Schilling B
Eur J Cancer; 2019 Jul; 116():207-215. PubMed ID: 31212163
[TBL] [Abstract][Full Text] [Related]
35. Meningeal Melanomatosis with a Spinal Meningeal Melanocytoma Trigger by an
Ramos AA; Ferrara P; Fernández VM; Sanchez CR; Alvarez Vega MA
Neurol India; 2022; 70(Supplement):S318-S321. PubMed ID: 36412389
[TBL] [Abstract][Full Text] [Related]
36. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy.
Shi DD; Arnaout O; Bi WL; Buchbinder EI; Cagney DN; Insco ML; Liu D; Schoenfeld JD; Aizer AA
World Neurosurg; 2020 Jul; 139():226-231. PubMed ID: 32330622
[TBL] [Abstract][Full Text] [Related]
37. [A case of leptomeningeal melanomatosis with acute paraplegia and multiple cranial nerve palsies].
Hattori K; Matsuda N; Murakami T; Ito E; Ugawa Y
Rinsho Shinkeigaku; 2017 Dec; 57(12):769-774. PubMed ID: 29187689
[TBL] [Abstract][Full Text] [Related]
38. Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis.
Boutros A; Tanda ET; Croce E; Catalano F; Ceppi M; Bruzzone M; Cecchi F; Arecco L; Fraguglia M; Pronzato P; Genova C; Del Mastro L; Lambertini M; Spagnolo F
Eur J Cancer; 2023 Jul; 188():64-79. PubMed ID: 37196485
[TBL] [Abstract][Full Text] [Related]
39. Nivolumab as adjuvant treatment for a spinal melanocytoma: A case report.
Hean V; Bouleftour W; Ramirez C; Forest F; Boutet C; Rivoirard R
Medicine (Baltimore); 2021 May; 100(19):e25862. PubMed ID: 34106633
[TBL] [Abstract][Full Text] [Related]
40. Primary diffuse meningeal melanomatosis.
Zadro I; Brinar VV; Barun B; Ozretić D; Pazanin L; Grahovac G; Habek M
Neurologist; 2010 Mar; 16(2):117-9. PubMed ID: 20220448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
